03.31.15
PAREXEL has introduced the latest version of its Regulatory Information Management (RIM) platform: LIQUENT InSight 6.0 to support the regulatory product lifecycle from early planning of registration targets through product retirement, with submission planning, publishing, viewing and registration management capabilities.
Enhancements to the LIQUENT InSight platform include:added analytics to enhance reporting capabilities, simplified interface designed to provide an intuitive experience to all levels of users, updated data model and architecture to help ensure processes, output and work product compliance with standards such as XEVMPD and the upcoming IDMP mandate, and revamped interoperability web services features that help systems interact and communicate with each other.
“LIQUENT InSight 6.0 simplifies navigation of the global regulatory environment and provides the submission and registration management tools needed to more quickly bring treatments to market and effectively maintain them throughout their lifespan,” said Xavier Flinois, president, PAREXEL Informatics. “As an essential part of the drug development journey, the LIQUENT InSight platform centralizes a company’s regulatory information to drive standardization, improve collaboration, and helps to ensure compliance, eliminate waste, reduce costs, and increase efficiencies so more patients can quickly and safely receive the treatments they need.”
Enhancements to the LIQUENT InSight platform include:added analytics to enhance reporting capabilities, simplified interface designed to provide an intuitive experience to all levels of users, updated data model and architecture to help ensure processes, output and work product compliance with standards such as XEVMPD and the upcoming IDMP mandate, and revamped interoperability web services features that help systems interact and communicate with each other.
“LIQUENT InSight 6.0 simplifies navigation of the global regulatory environment and provides the submission and registration management tools needed to more quickly bring treatments to market and effectively maintain them throughout their lifespan,” said Xavier Flinois, president, PAREXEL Informatics. “As an essential part of the drug development journey, the LIQUENT InSight platform centralizes a company’s regulatory information to drive standardization, improve collaboration, and helps to ensure compliance, eliminate waste, reduce costs, and increase efficiencies so more patients can quickly and safely receive the treatments they need.”